ChatGPT and the American Medical Association

from Sept. 12, 2023 Today.com

Dr. Jesse M. Ehrenfeld, president of leading U.S. physicians’ group the American Medical Association, tells TODAY.com in a statement that the AMA “supports deployment of high-quality, clinically validated AI that is deployed in a responsible, ethical, and transparent manner with patient safety being the first and foremost concern. While AI products show tremendous promise in helping alleviate physician administrative burdens and may ultimately be successfully utilized in direct patient care, OpenAI’s ChatGPT and other generative AI products currently have known issues and are not error free.”

He adds that “the current limitations create potential risks for physicians and patients and should be utilized with appropriate caution at this time. AI-generated fabrications, errors, or inaccuracies can harm patients, and physicians need to be acutely aware of these risks and added liability before they rely on unregulated machine-learning algorithms and tools.”

“Just as we demand proof that new medicines and biologics are safe and effective, so must we insist on clinical evidence of the safety and efficacy of new AI-enabled healthcare applications,” Ehrenfeld concludes.